Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study.

ABSTRACT: Recent studies raised concerns about the increasing use of gabapentinoids in different countries. With their potential for misuse and addiction, understanding the global consumption of gabapentinoids will offer us a platform to examine the need for any interventional policies. This longitudinal trend study utilised pharmaceutical sales data from 65 countries and regions across the world to evaluate the global trends in gabapentinoid consumption between 2008-2018. The multinational average annual percentage change of gabapentinoid consumption was +17.20%, increased from 4.17 defined daily dose per ten thousand inhabitants per day (DDD/TID) in 2008 to 18.26 DDD/TID in 2018. High-income countries had the highest pooled gabapentinoid consumption rate (39.92 DDD/TID) in 2018, which was more tha

SUBMITTER: Chan AYL 

PROVIDER: S-EPMC10435503 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature